Literature DB >> 8875564

Differentiation of Entamoeba histolytica and E. dispar DNA from cysts present in stool specimens by polymerase chain reaction: its field application in the Philippines.

W L Rivera1, H Tachibana, M R Silva-Tahat, H Uemura, H Kanbara.   

Abstract

It has been established that two distinct species exist within what was originally known as Entamoeba histolytica. These are E. dispar and E. histolytica, for the nonpathogenic and pathogenic forms, respectively. Differentiation of these two organisms is of great clinical importance since they are morphologically indistinguishable and both forms can infect the human intestinal cavity to different degrees. A simple and rapid DNA-extraction method that can be used directly on formalin-fixed stool specimens has been developed. The extracted DNA was used for the identification of the species existing in the stools by polymerase chain reaction (PCR). A total of 72 randomly collected stool samples from the Philippines were analyzed. In all, 19 samples reacted with E. dispar primers, resulting in the expected 101-bp PCR products; however, none reacted with E. histolytica primers. Furthermore, sensitivity assay suggests that genomic DNA from as few as five cysts can be used as a template for PCR. These observations imply that the use of genomic DNA directly extracted from formalin-fixed stool specimens for PCR amplification is a useful tool for obtaining a sensitive and accurate diagnosis that can be applied even in epidemiology studies.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8875564     DOI: 10.1007/s004360050169

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  20 in total

1.  Preparation of a monoclonal antibody specific for Entamoeba dispar and its ability to distinguish E. dispar from E. histolytica.

Authors:  H Tachibana; S Kobayashi; Y Kaneda; T Takeuchi; T Fujiwara
Journal:  Clin Diagn Lab Immunol       Date:  1997-07

2.  18S ribosomal DNA genotypes of Acanthamoeba species isolated from contact lens cases in the Philippines.

Authors:  Windell L Rivera; Davin Edric V Adao
Journal:  Parasitol Res       Date:  2009-06-28       Impact factor: 2.289

3.  Diagnosis and molecular characterization of Trichomonas vaginalis in sex workers in the Philippines.

Authors:  Macario Ireneo P Queza; Windell L Rivera
Journal:  Pathog Glob Health       Date:  2013-04       Impact factor: 2.894

4.  Molecular characterization of Blastocystis isolates in the Philippines by riboprinting.

Authors:  Windell L Rivera; Michael Alfred V Tan
Journal:  Parasitol Res       Date:  2005-05-11       Impact factor: 2.289

5.  Prevalence and genetic diversity of Entamoeba histolytica in an institution for the mentally retarded in the Philippines.

Authors:  Windell L Rivera; Sherwin R Santos; Hiroji Kanbara
Journal:  Parasitol Res       Date:  2005-11-12       Impact factor: 2.289

6.  Molecular characterization of Trichomonas vaginalis isolates from the Philippines.

Authors:  Windell L Rivera; Vanissa A Ong; Marvin C Masalunga
Journal:  Parasitol Res       Date:  2009-09-25       Impact factor: 2.289

Review 7.  Laboratory diagnosis of amebiasis.

Authors:  Mehmet Tanyuksel; William A Petri
Journal:  Clin Microbiol Rev       Date:  2003-10       Impact factor: 26.132

8.  Evaluation of recombinant fragments of Entamoeba histolytica Gal/GalNAc lectin intermediate subunit for serodiagnosis of amebiasis.

Authors:  Hiroshi Tachibana; Xun-Jia Cheng; Gohta Masuda; Noriyuki Horiki; Tsutomu Takeuchi
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

9.  Entamoeba histolytica and E. dispar infections in captive macaques (Macaca fascicularis) in the Philippines.

Authors:  Windell L Rivera; John Anthony D L Yason; Davin Edric V Adao
Journal:  Primates       Date:  2009-10-28       Impact factor: 2.163

10.  Ultrastructural study of a tetratrichomonad isolated from pig fecal samples.

Authors:  Windell L Rivera; Albert Joseph B Lupisan; John Michael P Baking
Journal:  Parasitol Res       Date:  2008-08-07       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.